优化多病共存多重用药老年患者的处方(OPTICA):整群随机临床试验
在瑞士基层医疗开展整群随机试验,纳入≥65岁、≥3种慢性病且≥5种长期用药的患者323例,比较以电子临床决策支持系统(eCDSS)为核心的药物审查干预与常规用药讨论。12个月时,药物适宜性改善(OR 1.05,95%CI 0.59–1.87)和处方遗漏数(0.90,0.41–1.96)的结果均不确定,但干预可安全实施。
要点
- eCDSS药物审查干预未显示改善药物适宜性或减少处方遗漏的明确证据。
- 干预组与对照组在12个月安全结局上无明确差异,干预未造成伤害。
- 每例患者平均报告实施1条停药或加药建议。
核心结论
- 以eCDSS为核心的药物审查干预相比常规用药讨论,在12个月时对药物适宜性改善和处方遗漏减少的结果均不确定。
- 干预可安全实施,未对患者造成伤害。
研究设计与样本
- 整群随机临床试验,在瑞士基层医疗开展,时间为2018年12月至2021年2月。
- 纳入≥65岁、≥3种慢性病且≥5种长期用药的患者,共43个全科医生集群、323例患者。
- 干预组21名全科医生、160例患者;对照组22名全科医生、163例患者。
主要发现
- 12个月时药物适宜性改善的意向性分析OR为1.05(95%CI 0.59–1.87),结果不确定。
- 12个月时处方遗漏数的意向性分析OR为0.90(95%CI 0.41–1.96),结果不确定。
- 符合方案分析结果与意向性分析一致,均不确定。
- 12个月随访未发现安全结局差异的明确证据,但干预组6个月和12个月报告的安全事件少于对照组。
- 每例患者平均报告实施1条停药或加药建议。
临床怎么用
- 在基层医疗中可安全实施以eCDSS为核心的药物审查干预,但不应期望其明确改善药物适宜性或减少处方遗漏。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the effects of a primary care medication review intervention centred around an electronic clinical decision support system (eCDSS) on appropriateness of medication and the number of prescribing omissions in older adults with multimorbidity and polypharmacy compared with a discussion about medication in line with usual care. DESIGN: Cluster randomised clinical trial. SETTING: Swiss primary care, between December 2018 and February 2021. PARTICIPANTS: Eligible patients were ≥65 years of age with three or more chronic conditions and five or more long term medications. INTERVENTION: The intervention to optimise pharmacotherapy centred around an eCDSS was conducted by general practitioners, followed by shared decision making between general practitioners and patients, and was compared with a discussion about medication in line with usual care between patients and general practitioners. MAIN OUTCOME MEASURES: Primary outcomes were improvement in the Medication Appropriateness Index (MAI) and the Assessment of Underutilisation (AOU) at 12 months. Secondary outcomes included number of medications, falls, fractures, and quality of life. RESULTS: In 43 general practitioner clusters, 323 patients were recruited (median age 77 (interquartile range 73-83) years; 45% (n=146) women). Twenty one general practitioners with 160 patients were assigned to the intervention group and 22 general practitioners with 163 patients to the control group. On average, one recommendation to stop or start a medication was reported to be implemented per patient. At 12 months, the results of the intention-to-treat analysis of the improvement in appropriateness of medication (odds ratio 1.05, 95% confidence interval 0.59 to 1.87) and the number of prescribing omissions (0.90, 0.41 to 1.96) were inconclusive. The same was the case for the per protocol analysis. No clear evidence was found for a difference in safety outcomes at the 12 month follow-up, but fewer safety events were reported in the intervention group than in the control group at six and 12 months. CONCLUSIONS: In this randomised trial of general practitioners and older adults, the results were inconclusive as to whether the medication review intervention centred around the use of an eCDSS led to an improvement in appropriateness of medication or a reduction in prescribing omissions at 12 months compared with a discussion about medication in line with usual care. Nevertheless, the intervention could be safely delivered without causing any harm to patients. TRIAL REGISTRATION: NCT03724539Clinicaltrials.gov NCT03724539.
引用
- Jungo KT, Ansorg AK, Floriani C, et al. Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial. BMJ. 2023. PMID: 37225248. doi:10.1136/bmj-2022-074054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。